Literature DB >> 20803821

Nephrotic syndrome with pegylated interferon alfa 2a and ribavirin for a patient with chronic hepatitis C.

Ajit Sood, Vandana Midha, Jaswinder S Sandhu, Neena Sood, Amarjit Kaur, Rasham Mittal, Sandeep Puri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20803821

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  10 in total

1.  Collapsing focal segmental glomerulosclerosis with recovery of renal function: an uncommon complication of interferon therapy for hepatitis C.

Authors:  D F Stein; A Ahmed; V Sunkhara; W Khalbuss
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 2.  Hepatitis C and renal disease: an update.

Authors:  Catherine M Meyers; Leonard B Seeff; Catherine O Stehman-Breen; Jay H Hoofnagle
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

3.  De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection.

Authors:  Jose L Tovar; Maria Buti; Alfonso Segarra; Joaquim Majó; Rafael Esteban
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

4.  Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C.

Authors:  Cláudia Alves Couto; Luciana Costa Faria; Daniel Dias Ribeiro; Kátia de Paula Farah; Osvaldo Flávio de Melo Couto; Teresa Cristina de Abreu Ferrari
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

Review 5.  Reversible renal failure in a patient with the hypereosinophilia syndrome during therapy with alpha interferon.

Authors:  G M Nassar; P Pedro; R E Remmers; L B Mohanty; W Smith
Journal:  Am J Kidney Dis       Date:  1998-01       Impact factor: 8.860

6.  Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy.

Authors:  E Coroneos; G Petrusevska; F Varghese; L D Truong
Journal:  Am J Kidney Dis       Date:  1996-12       Impact factor: 8.860

7.  Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.

Authors:  G J Jones; L M Itri
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

Review 8.  Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C.

Authors:  Richard A Willson
Journal:  J Clin Gastroenterol       Date:  2002-07       Impact factor: 3.062

Review 9.  Clinical toxicity of interferons in cancer patients: a review.

Authors:  J R Quesada; M Talpaz; A Rios; R Kurzrock; J U Gutterman
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

Review 10.  Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.

Authors:  CelesteAnn T Bremer; Ashton Lastrapes; Arnold B Alper; Raja Mudad
Journal:  Am J Clin Oncol       Date:  2003-06       Impact factor: 2.339
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.